anti-MCPyV TCR T-cell therapy (Affini-T Therapeutics)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-MCPyV TCR T-cell therapy (Affini-T Therapeutics)

Drug Alias Nameviral oncoprotein TCR T cell therapy (Affini-T Therapeutics)MCPyV targeted TCR T-cell therapy (Affini-T Therapeutics)

ClassificationBiologics > Protein drugs > Recombinant proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionHuman leukocyte antigen modulators

TargetsHuman leukocyte antigen

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesAffini-T Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesAffini-T Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A